Revco was on the verge of getting a higher bid.
- Share via
Sources familiar with the bidding for the Ohio drugstore chain operator said a management group was planning to sweeten its offer for a leveraged buyout. Wall Street speculation has suggested a price of about $38 a share for the company, or about $1.27 billion. Last March, the group offered $33 a share, an amount that a special panel of outside directors said was too low.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
More From the Los Angeles Times
Podcasts
A series of small-town dog killings was a prelude to the violence committed by one of California’s deadliest serial killers.
The stories behind the most compelling cases from the people who know them best.
From punchlines to policy, comedian Esteban Gast and Sammy Roth explore laughter as a powerful tool for change.
